DiaCarta Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:$53M
Industry:Biotech
Founded:2010
Lead Investor(s):Fortune Fountain Capital
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • DiaCarta's estimated annual revenue is currently $6.7M per year.
  • DiaCarta received $45.0M in venture funding in February 2018.
  • DiaCarta's estimated revenue per employee is $155,000
  • DiaCarta's total funding is $53M.

Employee Data

  • DiaCarta has 43 Employees.
  • DiaCarta grew their employee count by 10% last year.
  • DiaCarta currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.7M4310%N/A
Mission Bio
$11.5M7445%N/A
Geron Corporati...
N/A197N/AN/A
Rigel Pharmaceu...
$45M2904%N/A
Althea Technolo...
$21.4M138N/AN/A
INOVA Diagnosti...
$37.5M242N/AN/A
ProTrials Resea...
$28.2M1823%N/A
Trace Genomics
$6.4M4137%N/A
Advanced Cell D...
$27.6M1788%N/A
The J. Craig Ve...
$33.3M215N/AN/A
Missing a competitor? Contribute!?
Submit

DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

43

Number of Employees

$6.7M

Revenue (est)

1

Current Jobs

10%

Employee Growth %

$53M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Yulei ShangProduction ManagerEmail Available
Elena PeletskayaDirector, Molecular Analytics, Juno Therapeutics
Aiguo ZhangFounder, President & CEOEmail Available
Michael PowellChief Scientific OfficerEmail Available
Nitin UdarSr. Vp Diagnostics And RegulatoryEmail Available
Ray MengSenior Manager, Product Managment And System IntegrationEmail Available
Effie HoGeneral ManagerEmail Available
Claudia LiManager Of Digital Marketing And Marketing CommunicationEmail Available
Wei LiuSr. Dir of Product Management & MarketingEmail Available
Jinwei DuManager, IVD DevelopmentEmail Available

DiaCarta News

10/15/2018 - DiaCarta, Inc., Awarded $2 Million NCI Contract to Pursue ...

BUSINESS WIRE)--DIACARTA, Inc., a precision diagnostic company and leading developer of products for nucleic acid-based detection ...

01/17/2019 - CIO Bulletin Announces DiaCarta Inc. As One of the 30 ...

RICHMOND, Calif.--(BUSINESS WIRE)--DiaCarta today announced that CIO Bulletin has named it among the 30 Fastest Growing Companies ...

02/12/2018 - DiaCarta Raises $45M in Series B Funding

NEW YORK (GenomeWeb) – DiaCarta said today that it has completed a Series B funding round, raising a total of $45 million. The second ...

DiaCarta Funding

DateAmountRoundLead InvestorsReference
2015-01-12$8.0MABVCFArticle
2018-02-13$45.0MBFortune Fountain CapitalArticle